| Hoon Joo Lee, PHARMD | |
|
6900 Georgia Ave Nw, Washington, DC 20307-0003 | |
| (202) 782-3946 | |
| Not Available |
| Full Name | Hoon Joo Lee |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 6900 Georgia Ave Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164568473 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 15696 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Hoon Joo Lee, PHARMD 23416 Arora Hills Dr, Clarksburg, MD 20871-3305 Ph: () - | Hoon Joo Lee, PHARMD 6900 Georgia Ave Nw, Washington, DC 20307-0003 Ph: (202) 782-3946 |
News Archive
Actavis plc, during its Investor Meeting in New York, today provided a detailed look into its standalone global pharmaceutical development pipeline that supports the Company's long-term organic growth. The Company provided details regarding key development programs, including clinical data, development milestones and an overview of potential market opportunities, as well as an updated look at Actavis' world-class generics pipeline, which continues to hold an industry-leading position in First-to-File opportunities in the U.S.
Researchers at the National Institute of Mental Health have identified a relationship between a small section of one gene, the brain chemical messenger glutamate, and a collection of traits known to be associated with schizophrenia.
A new study suggests that acute leukemia patients whose cancer cells show a genetic change that usually predicts a swift return of the disease following remission may remain disease-free longer when given aggressive therapy.
Theraclone Sciences, Inc., a therapeutic antibody discovery and development company, announced today that they have entered into a multi-year research and development collaboration with Pfizer. The collaboration will use Theraclone's I-STAR™ technology to discover broadly protective monoclonal antibodies against up to four undisclosed targets in the areas of infectious disease and cancer.
The National Cancer Institute has awarded a five-year, $10.7 million grant to Virginia Commonwealth University Massey Cancer Center researchers to develop a new form of radiation therapy that will enable the safe administration of more aggressive cancer treatments.
› Verified 5 days ago
Juliana O Anamelechi, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 50 Irving St Nw, Washington, DC 20422 Phone: 202-745-8000 | |
Reine Kamtcheu Lienou, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7600 Georgia Ave Nw, Suite 323, Washington, DC 20012 Phone: 202-723-3060 Fax: 202-723-3065 | |
Gina Jin Lee, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-4080 | |
Dr. Bruce Cofane, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 845 Bladensburg Rd Ne, Washington, DC 20002 Phone: 202-397-2600 | |
Mesay Abebe, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3100 14th St Nw, Washington, DC 20010 Phone: 202-777-3774 | |
Dr. Salome K Bwayo, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2300 4th St Nw, Washington, DC 20059 Phone: 202-806-7262 Fax: 202-806-4478 | |
Tracy Doney, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 110 Irving St Nw, Rm B147, Washington, DC 20010 Phone: 202-877-6747 |